The study also revealed that the antibody profile in the blood of people who have had the virus is extremely variable and this may modify the response to the treatment
A McMaster team of researchers has found how the COVID-19 vaccines that use adenovirus vectors trigger a rare but sometimes fatal blood clotting reaction called vaccine-induced immune thrombotic thrombocytopenia or VITT.
Behind the scenes at the McMaster Platelet Immunology Laboratory, scientists are studying a cell so tiny it was once called 'blood dust'.